subject: CHEBI:46662

subject_name: mineral

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:71255

subject_name: Asenapine

object_name: bipolar disorder

tested_intervention: unsure


subject: CHEBI:71256

subject_name: (R,R)-asenapine


subject: GTOPDB:13876

subject_name: nipocalimab

object_name: myasthenia gravis


subject: GTOPDB:13876

object_name: Myasthenia Gravis, CTCAE


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UNII:87M90CV8NC


subject: UMLS:C5417823


subject: UMLS:C5417823


subject: PUBCHEM.COMPOUND:135483998

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:135483998

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:135483998

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:135483998

object_name: Depression, CTCAE


subject: CHEBI:136009

subject_name: L-Methylfolate


subject: CHEBI:136009


subject: CHEBI:136009


subject: CHEBI:136009


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: PUBCHEM.COMPOUND:135565610

subject_name: hetrombopag

object_name: liver disorder


subject: PUBCHEM.COMPOUND:135565610

object_name: Decreased liver function


subject: UNII:9WGT51BDDL

subject_name: Hetrombopag


subject: UNII:9WGT51BDDL


subject: CHEBI:23359

subject_name: colchicine

object_name: liver carcinoma

tested_intervention: yes


subject: CHEBI:23359

object_name: Tumor Cell Invasion


subject: CHEBI:23359

object_name: Cell Invasion


subject: CHEBI:23359

object_name: Embolism, Tumor


subject: CHEBI:23359

object_name: Neoplasm Metastasis


subject: CHEBI:23359

object_name: Metastasis


subject: CHEBI:23359

object_name: Metastatic Lesion


subject: CHEBI:49140

object_name: cholecystitis


subject: CHEBI:49140

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:49140

object_name: Cholecystitis, CTCAE 5.0


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: colorectal neoplasm


subject: CHEBI:233644

subject_name: Senicapoc

object_name: allergic asthma


subject: CHEBI:233644

object_name: IgE-mediated allergic asthma


subject: CHEBI:233644

object_name: extrinsic asthma


subject: PUBCHEM.COMPOUND:11255911

subject_name: Tesofensine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:11255911

object_name: obesity


subject: PUBCHEM.COMPOUND:11255911

object_name: Obesity, CTCAE


subject: UMLS:C3828699

subject_name: Oraxol

object_name: Childhood Solid Neoplasm


subject: UMLS:C3828699

object_name: Adult Solid Neoplasm


subject: UMLS:C3828699

object_name: Solid Neoplasm


subject: CHEBI:5181

subject_name: fucoidan

object_name: Radiation Sickness


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: superficial urinary bladder carcinoma


subject: CHEBI:3219

subject_name: Bupropion

object_name: alcohol abuse


subject: CHEBI:3219

object_name: alcohol dependence


subject: UNII:SE2KH7T06F

object_name: Advanced Breast Carcinoma


subject: UNII:SE2KH7T06F

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C4287766

object_name: Advanced breast cancer


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: CHEBI:64073

object_name: maturity-onset diabetes of the young type 1


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEBI:30742

subject_name: macrogol

object_name: hepatitis C


subject: CHEBI:30742

object_name: chronic hepatitis C virus infection


subject: PR:000012224

subject_name: glycodelin


subject: PR:000012224


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: Intermediate Risk Prostate Carcinoma


subject: PUBCHEM.COMPOUND:44151801

object_name: Localized Prostate Carcinoma


subject: PUBCHEM.COMPOUND:44151801

object_name: Castration-Naive Prostate Carcinoma


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: uveal melanoma


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:233644

object_name: Alzheimer disease type 1


subject: CHEBI:233644

object_name: Alzheimer disease


subject: CHEBI:233644

object_name: mild neurocognitive disorder


subject: CHEBI:233644

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:19609831

subject_name: Rebimastat

object_name: lung cancer


subject: PUBCHEM.COMPOUND:19609831

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:19609831

object_name: lung carcinoma


subject: CHEBI:8499

subject_name: Propranolol

object_name: Kinetic tremor


subject: CHEBI:8499

object_name: Voice tremor


subject: CHEBI:8499

object_name: Vocal tremor


subject: CHEBI:230801

subject_name: Morinidazole

object_name: appendicitis


subject: CHEBI:230801

object_name: Appendicitis, CTCAE


subject: CHEBI:45783

subject_name: Imatinib

object_name: chronic graft versus host disease


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: Nocturia


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: UMLS:C2703114

object_name: metastatic colorectal cancer


subject: UNII:TC549UFL8P

object_name: Crohn disease


subject: UMLS:C1831848


subject: CHEBI:94705

object_name: oral candidiasis


subject: CHEBI:94705

object_name: HIV infection


subject: CHEBI:9448

subject_name: Terbinafine


subject: CHEBI:9448


subject: CHEBI:40618

subject_name: Pimagedine

object_name: asthma


subject: MESH:D010919

subject_name: Placebos


subject: CHEBI:5296

subject_name: Gemfibrozil

object_name: coronary artery disorder


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: myocardial infarction


subject: UMLS:C0085826

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C0085826

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0085826

object_name: heart failure


subject: UMLS:C0085826

object_name: Heart Failure, CTCAE


subject: UNII:5W8JGG2651

subject_name: Idursulfase

object_name: Hunter Syndrome


subject: PR:000008894

subject_name: iduronate 2-sulfatase


subject: CHEMBL.COMPOUND:CHEMBL4594537

subject_name: TIVIDENOFUSP ALFA


subject: UMLS:C5814285

subject_name: Tividenofusp alfa


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: hypoactive sexual desire disorder


subject: CHEBI:28689

subject_name: Prasterone


subject: UMLS:C4043330

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:163797

object_name: malaria


subject: UniProtKB:P58239

subject_name: CNMD_DANRE Leukocyte cell-derived chemotaxin 1 (sprot)


subject: PR:000009749


subject: CHEBI:31689

subject_name: Iguratimod


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: Plasmodium falciparum malaria


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:3638

subject_name: Chloroquine


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: hand dermatosis


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:53498

subject_name: triacetylcellulose


subject: UMLS:C2962221

subject_name: TAC


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: insomnia


subject: UNII:0K5743G68X

object_name: Insomnia, CTCAE 3.0


subject: UNII:0K5743G68X

object_name: Insomnia, CTCAE 5.0


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:54671203

object_name: Dyspepsia, CTCAE


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: UNII:6GNT3Y5LMF


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:94807

subject_name: Nitazoxanide


subject: CHEBI:94807


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UMLS:C1268876

subject_name: follitropin alfa

object_name: infertility


subject: MESH:C551396

subject_name: pergoveris


subject: GTOPDB:4391

subject_name: LH


subject: CHEBI:74539

subject_name: Leu-His


subject: CHEBI:81568

subject_name: luteinizing hormone


subject: CHEBI:167574

subject_name: Semaglutide


subject: CHEBI:167574


subject: CHEBI:36791

subject_name: Escitalopram

object_name: spinal cord injury


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:74088

object_name: Carcinoma breast stage IV


subject: CHEBI:74088

object_name: Childhood Breast Carcinoma


subject: CHEBI:74088

object_name: breast carcinoma


subject: CHEBI:74088

object_name: breast cancer


subject: CHEBI:74088

object_name: Her2-receptor negative breast cancer


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:73805


subject: UMLS:C4744361

subject_name: AKT Inhibitor


subject: UMLS:C4744361


subject: UMLS:C4744361


subject: UMLS:C4744361


subject: UMLS:C4744361

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C4744361


subject: UNII:OWV057OPZ3

subject_name: PARPI


subject: UNII:OWV057OPZ3


subject: UNII:OWV057OPZ3


subject: UNII:OWV057OPZ3


subject: UNII:OWV057OPZ3


subject: UNII:OWV057OPZ3


subject: UMLS:C1519050

subject_name: PI3K inhibitors


subject: UMLS:C1519050


subject: UMLS:C1519050


subject: UMLS:C1519050


subject: UMLS:C1519050


subject: UMLS:C1519050


subject: CHEBI:50914

subject_name: EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor


subject: CHEBI:50914


subject: CHEBI:50914


subject: CHEBI:50914


subject: CHEBI:50914


subject: CHEBI:50914


subject: UMLS:C1519228

subject_name: Selective Estrogen Receptor Down Regulator


subject: UMLS:C1519228


subject: UMLS:C1519228


subject: UMLS:C1519228


subject: UMLS:C1519228


subject: UMLS:C1519228


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: CHEBI:68481

subject_name: mTOR inhibitor


subject: CHEBI:68481


subject: CHEBI:68481


subject: CHEBI:68481


subject: CHEBI:68481


subject: CHEBI:68481


subject: UMLS:C2746052

subject_name: MTOR Inhibitors


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: MESH:D020845

subject_name: Selective Estrogen Receptor Modulators


subject: MESH:D020845


subject: MESH:D020845


subject: MESH:D020845


subject: MESH:D020845


subject: MESH:D020845


subject: UMLS:C3536982

subject_name: Estrogen Agonist/Antagonist [EPC]


subject: UMLS:C3536982


subject: UMLS:C3536982


subject: UMLS:C3536982


subject: UMLS:C3536982


subject: UMLS:C3536982


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: osteoporosis-pseudoglioma syndrome


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: bipolar I disorder


subject: CHEBI:8707

subject_name: Quetiapine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: adult germ cell tumor


subject: PUBCHEM.COMPOUND:2767

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:2767

object_name: childhood germ cell tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Germ Cell Cancer


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:90205

subject_name: Plitidepsin

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:73313844

subject_name: Dehydrodidemnin B


subject: PUBCHEM.COMPOUND:57503717

subject_name: APLIDIN


subject: UMLS:C0388638

subject_name: plitidepsin


subject: GTOPDB:8002

subject_name: bavituximab

object_name: gastroesophageal cancer


subject: GTOPDB:8002

object_name: Stomach cancer


subject: GTOPDB:8002

object_name: gastric cancer


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C0004149

subject_name: ATGAM

object_name: Severe Aplastic Anemia


subject: UMLS:C0004149

object_name: severe aplastic anemia


subject: CHEBI:55379

subject_name: camphorsulfonic acid


subject: CHEBI:55379


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: PR:000007170


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: uveitis


subject: UNII:FU77B4U5Z0

object_name: Uveitis, CTCAE


subject: GTOPDB:13769

subject_name: retatrutide

object_name: type 2 diabetes mellitus


subject: GTOPDB:13769

object_name: Overweight or obesity


subject: GTOPDB:13769

object_name: chronic kidney disease


subject: CHEMBL.COMPOUND:CHEMBL5095485

subject_name: RETATRUTIDE


subject: CHEMBL.COMPOUND:CHEMBL5095485


subject: CHEMBL.COMPOUND:CHEMBL5095485


subject: UMLS:C2605669

subject_name: Clotinab

object_name: myocardial infarction


subject: UMLS:C2605669

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C2605669

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:231614

subject_name: Nivolumab

object_name: diffuse large B-cell lymphoma


subject: UMLS:C2346820


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: sinusitis


subject: UNII:6GNT3Y5LMF

object_name: Sinusitis, CTCAE


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Metastatic Bone Disease


subject: UNII:4EQZ6YO2HI

object_name: Childhood Solid Neoplasm


subject: UNII:4EQZ6YO2HI

object_name: Adult Solid Neoplasm


subject: UNII:4EQZ6YO2HI

object_name: Solid Neoplasm


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:7903

subject_name: Pamidronic acid


subject: CHEBI:7903


subject: CHEBI:7903


subject: CHEBI:7903


subject: CHEBI:75984

subject_name: Flecainide

object_name: paroxysmal atrial fibrillation


subject: CHEBI:75984

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: CHEBI:135956

subject_name: Vernakalant


subject: CHEBI:135956


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Heartburn


subject: CHEBI:6375

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C3852696

object_name: malaria


subject: UNII:3I8JKL1CHB

object_name: ovarian cancer


subject: UNII:3I8JKL1CHB

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C3641173

subject_name: PROMITIL


subject: UMLS:C3641173


subject: CHEBI:229661

subject_name: Omaveloxolone

object_name: Friedreich ataxia


subject: CHEBI:229661

object_name: Friedreich ataxia 1


subject: CHEBI:74947

subject_name: Thalidomide

object_name: portal hypertension


subject: CHEBI:74947

object_name: Portal Hypertension, CTCAE


subject: CHEBI:74947

object_name: Gastrointestinal hemorrhage


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan

object_name: oral candidiasis


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:16261

subject_name: chitosan


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: biliary tract cancer


subject: UNII:B2K5L1L8S9

object_name: liver carcinoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: complication


subject: PUBCHEM.COMPOUND:9861622

subject_name: Ecopipam

object_name: Lesch-Nyhan syndrome


subject: PUBCHEM.COMPOUND:9861622

object_name: Self-injurious behavior


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Depression, psychotic


subject: CHEBI:50692

object_name: Severe major depression with psychotic features


subject: CHEBI:50692

object_name: psychosis


subject: CHEBI:50692

object_name: Nonorganic psychosis


subject: CHEBI:50692

object_name: Psychosis, CTCAE


subject: CHEBI:6801

subject_name: Metformin

object_name: Premature birth


subject: CHEBI:6801

object_name: pregnancy preterm


subject: CHEBI:6801

object_name: pregnancy disorder


subject: CHEBI:6801

object_name: twin; complicating pregnancy


subject: CHEBI:6801

object_name: Premature Labor


subject: CHEBI:6801

object_name: Drug action (disorder)


subject: CHEBI:31596

subject_name: Febuxostat

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: aortic stenosis


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6

object_name: mild neurocognitive disorder


subject: UNII:4F4X42SYQ6

object_name: mild cognitive impairment


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:621XR2W6OP

subject_name: Methylprednisone


subject: UNII:621XR2W6OP


subject: UNII:621XR2W6OP


subject: PUBCHEM.COMPOUND:5126752


subject: PUBCHEM.COMPOUND:5126752


subject: PUBCHEM.COMPOUND:5126752


subject: CHEBI:135573

subject_name: Meprednisone


subject: CHEBI:135573


subject: CHEBI:135573


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UNII:I031V2H011

object_name: B-cell acute lymphoblastic leukemia


subject: UNII:I031V2H011

object_name: Lymphoblastic B-cell lymphoma


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: diabetes mellitus


subject: UMLS:C3475162

subject_name: phentermine / topiramate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3475162

object_name: obesity


subject: UMLS:C3475162

object_name: Obesity, CTCAE


subject: UMLS:C3475162

object_name: ulcerative colitis


subject: UMLS:C4764354

subject_name: Niagen

object_name: neuroaxonal dystrophy


subject: UMLS:C4764354

object_name: Atypical nevus


subject: UMLS:C4764354

object_name: patient appears in no acute distress (physical finding)


subject: RXCUI:1999664

subject_name: bictegravir / emtricitabine / tenofovir alafenamide Oral Product

object_name: HIV infection


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: beta thalassemia


subject: CHEBI:44423

object_name: beta-thalassemia HBB/LCRB


subject: CHEBI:8080

subject_name: Phentermine

object_name: hypertension


subject: CHEBI:8080

object_name: Hypertension, CTCAE


subject: CHEBI:8080


subject: CHEBI:8080


subject: CHEBI:8080


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: Stage I Uterine Corpus Cancer AJCC v8


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:201431

object_name: non-Hodgkin lymphoma


subject: CHEBI:201431

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:167450

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:9904258

object_name: focal epilepsy


subject: CHEBI:174358

subject_name: Eslicarbazepine


subject: CHEBI:7824

subject_name: Oxcarbazepine


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Heartburn


subject: CHEBI:7915

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: refractory malignant neoplasm


subject: CHEBI:7820

subject_name: Oxandrolone

object_name: HIV wasting syndrome


subject: CHEBI:31355

subject_name: Carboplatin

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095362

subject_name: VOLRUSTOMIG

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL5095362

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: UMLS:C5417881

subject_name: Volrustomig


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: UMLS:C1565518

subject_name: TMC 114

object_name: HIV infection


subject: CHEBI:72296

subject_name: Apixaban

object_name: nephrotic syndrome


subject: CHEBI:72296

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:72296

object_name: proteinuria


subject: CHEBI:72296

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:72296

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:72296

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Depressed mood


subject: CHEBI:192614

object_name: Cancer patients and suicide and depression


subject: CHEBI:192614

object_name: Depressed - symptom


subject: CHEBI:192614

object_name: Depression, CTCAE


subject: CHEBI:192614

object_name: sexual disorder


subject: CHEBI:192614

object_name: physiological sexual disorder


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: CHEBI:183660


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139


subject: MESH:C089739

object_name: skin melanoma


subject: UNII:DPT0O3T46P

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: corpus callosum, agenesis of


subject: UNII:DPT0O3T46P

object_name: Congenital scar


subject: CHEBI:60269

subject_name: trisodium phosphonoformate hexahydrate

object_name: cytomegalovirus retinitis


subject: CHEBI:60269

object_name: HIV infection


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Childhood Breast Carcinoma


subject: UMLS:C1527137

object_name: breast carcinoma


subject: UMLS:C1527137

object_name: breast cancer


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Peripheral T-cell lymphoma unspecified refractory


subject: UNII:28X28X9OKV

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: recurrent cutaneous T-cell lymphoma


subject: UNII:28X28X9OKV

object_name: Mycosis fungoides refractory


subject: UNII:28X28X9OKV

object_name: Mycosis fungoides recurrent


subject: UNII:28X28X9OKV

object_name: folliculotropic mycosis fungoides


subject: UNII:28X28X9OKV

object_name: Sezary syndrome


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:53477758

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:53477758

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:53477758

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:53477758

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:53477758

object_name: major depressive disorder


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone


subject: PUBCHEM.COMPOUND:5470


subject: PUBCHEM.COMPOUND:5470


subject: PUBCHEM.COMPOUND:5470


subject: PUBCHEM.COMPOUND:5470


subject: PUBCHEM.COMPOUND:5470


subject: CHEBI:6121

subject_name: Ketamine

object_name: chronic pain (diagnosis)


subject: CHEBI:6121

object_name: Chronic pain


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEMBL.COMPOUND:CHEMBL4650509

subject_name: MIBAVADEMAB

object_name: Thinness


subject: UMLS:C5449393

subject_name: Mibavademab


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: acute respiratory distress syndrome


subject: UNII:WGD229O42W

object_name: adult acute respiratory distress syndrome


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage II Childhood Large Cell Lymphoma


subject: CHEBI:4026

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:4026

object_name: Stage I Childhood Large Cell Lymphoma


subject: CHEBI:4026

object_name: Stage IV Childhood Large Cell Lymphoma


subject: CHEBI:4026

object_name: Stage III Childhood Large Cell Lymphoma


subject: CHEBI:4026

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:4026

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:4026

object_name: Stage II Childhood Burkitt Lymphoma


subject: CHEBI:4026

object_name: Stage I Childhood Burkitt Lymphoma


subject: CHEBI:4026

object_name: Stage III Childhood Burkitt Lymphoma


subject: CHEBI:4026

object_name: Stage IV Childhood Burkitt Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Burkitt lymphoma


subject: CHEBI:91872

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2107910

object_name: prostate cancer


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: gastric adenocarcinoma


subject: CHEBI:41879

object_name: Carcinomatosis


subject: CHEBI:41879

object_name: carcinomatosis of unspecified behavior


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4975

subject_name: Famotidine


subject: CHEBI:4975


subject: CHEBI:4975


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: childhood kidney cell carcinoma


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: drug-induced liver injury


subject: PUBCHEM.COMPOUND:135512673

object_name: tuberculosis


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:6030

subject_name: Isoniazid


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:86217377

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:86217377

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:86217377

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:86217377

object_name: Urinary incontinence


subject: PUBCHEM.COMPOUND:86217377

object_name: Urinary Incontinence, CTCAE 5.0


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:144551


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Loss of hypoglycemic warning due to diabetes mellitus


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: High grade glioma


subject: PUBCHEM.COMPOUND:78162481

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:78162481

object_name: Grade III Childhood Astrocytoma


subject: PUBCHEM.COMPOUND:78162481

object_name: Adult Anaplastic Astrocytoma


subject: PUBCHEM.COMPOUND:78162481

object_name: anaplastic astrocytoma


subject: PUBCHEM.COMPOUND:78162481

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:78162481

object_name: grade III glioma


subject: PUBCHEM.COMPOUND:78162481

object_name: Diffuse Midline Glioma, H3 K27-Altered


subject: PUBCHEM.COMPOUND:78162481

object_name: diffuse midline glioma, H3 K27M-mutant


subject: PUBCHEM.COMPOUND:78162481

object_name: diffuse intrinsic pontine glioma


subject: PUBCHEM.COMPOUND:78162481

object_name: infant-type hemispheric glioma


subject: PUBCHEM.COMPOUND:78162481

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:78162481

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:78162481

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:78162481

object_name: adult glioblastoma


subject: UMLS:C5554607

subject_name: Obrixtamig

object_name: glioma


subject: UMLS:C5554607


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Immunization reaction


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5418026

subject_name: Osemitamab

object_name: biliary tract neoplasm


subject: UMLS:C2959261

subject_name: velaglucerase alfa 100 units injection

object_name: Gaucher disease type I


subject: UMLS:C2959261

object_name: Gaucher disease type III


subject: UNII:23HYE36B0I

subject_name: Velaglucerase alfa


subject: UNII:23HYE36B0I


subject: CHEBI:33569

subject_name: noradrenaline

object_name: adverse effect


subject: CHEBI:33569

object_name: Adverse effects


subject: CHEBI:33569

object_name: Adverse reactions


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:8093


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: atopic eczema


subject: UNII:420K487FSG

object_name: dermatitis


subject: UNII:420K487FSG

object_name: Eczema, CTCAE


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: cancer


subject: UMLS:C0728976

object_name: neoplasm


subject: UMLS:C0728976

object_name: Critical Illness


subject: UMLS:C0728976

object_name: Surgical procedure finding


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: brain astrocytoma


subject: GTOPDB:9592

object_name: astrocytic tumor


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UMLS:C1174786

subject_name: Pritor

object_name: hypertension


subject: GTOPDB:11644

subject_name: plonmarlimab

object_name: hemophagocytic syndrome


subject: CHEMBL.COMPOUND:CHEMBL4650518

subject_name: PLONMARLIMAB


subject: UMLS:C5417930


subject: CHEBI:184662

object_name: HIV-1 infection


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: PUBCHEM.COMPOUND:168152471

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:168152471

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:168152471

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:168152471

object_name: neoplasm of esophagus


subject: UMLS:C5854363

subject_name: SMARCA2 Degrader PRT3789


subject: UMLS:C5854363


subject: UMLS:C5854363


subject: UMLS:C5854363


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: SMARCA4 Gene Mutation


subject: CHEBI:3423

subject_name: Carmustine

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:3423

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:3423

object_name: enteropathy-associated T-cell lymphoma


subject: CHEBI:3423

object_name: monomorphic epitheliotropic intestinal T-cell lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: adult lymphoma


subject: UMLS:C0699319

object_name: lymphoma


subject: UMLS:C0699319

object_name: pediatric lymphoma


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:231598

subject_name: Tazemetostat


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: congenital heart disease


subject: UMLS:C2713972

subject_name: ZIO 101

object_name: Solid Neoplasm


subject: CHEBI:94295

subject_name: Darinaparsin


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: inherited lipid metabolism disorder


subject: CHEBI:5001

object_name: Dyslipidemia


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:135918

object_name: B-cell neoplasm


subject: CHEBI:23359

subject_name: colchicine

object_name: prostate carcinoma


subject: CHEBI:23359

object_name: prostate cancer


subject: UMLS:C4082808

subject_name: Advagraf

object_name: kidney disorder


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: psoriasis


subject: UMLS:C4078397


subject: CHEBI:229652

subject_name: Iptacopan

object_name: Hepatic impairment


subject: CHEBI:74705

subject_name: Met-Leu

object_name: pain agnosia


subject: CHEBI:74705

object_name: Pain insensitivity


subject: CHEBI:74705

object_name: opioid use


subject: CHEBI:74705

object_name: Acute Pain


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:131168

subject_name: Afuresertib

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Premature birth


subject: CHEBI:95021

subject_name: pemetrexed

object_name: trophoblastic neoplasm


subject: CHEBI:95021

object_name: uterine cancer


subject: CHEBI:95021

object_name: tumor of uterus


subject: CHEBI:95021

object_name: hydatidiform mole


subject: CHEBI:95021

object_name: gestational trophoblastic neoplasm


subject: CHEBI:95021

object_name: hydatidiform mole, recurrent, 1


subject: CHEBI:95021

object_name: uterine corpus choriocarcinoma


subject: CHEBI:95021

object_name: choriocarcinoma of testis


subject: CHEBI:95021

object_name: choriocarcinoma


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:32682

subject_name: L-argininium

object_name: hypertension


subject: CHEBI:32682

object_name: Hypertension, CTCAE


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:6933

subject_name: Midodrine

object_name: Irritable heart


subject: CHEBI:6933

object_name: neurocirculatory asthenia


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: acute myocardial infarction


subject: CHEBI:37941

object_name: Acute Myocardial Infarction by ECG Finding


subject: MESH:D007166

subject_name: Immunosuppressive Agents

object_name: adult dermatomyositis


subject: MESH:D007166

object_name: dermatomyositis


subject: MESH:D007166

object_name: polymyositis


subject: UMLS:C3852542

object_name: type 2 diabetes mellitus


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:16899

subject_name: Mannitol

object_name: pathologic hemodilution


subject: CHEBI:16899

object_name: coronary artery disorder


subject: CHEBI:16899

object_name: coronary atherosclerosis


subject: CHEBI:16899

object_name: Fluid Overload


subject: CHEBI:16899

object_name: Hypervolemia


subject: CHEBI:109549

subject_name: Ramelteon

object_name: sleep disorder


subject: CHEBI:109549

object_name: Lewy Bodies


subject: CHEBI:109549

object_name: Huntington disease


subject: CHEBI:109549

object_name: circadian rhythm sleep disorder


subject: CHEBI:109549

object_name: Parkinson disease


subject: CHEBI:53074

subject_name: Diphencyprone

object_name: Cutaneous neurofibroma


subject: PUBCHEM.COMPOUND:132212657

subject_name: Revumenib

object_name: leukemia


subject: PUBCHEM.COMPOUND:132212657

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:169490859

subject_name: Revumenib citrate


subject: PUBCHEM.COMPOUND:169490859


subject: MESH:C576493

subject_name: Meopa

object_name: acute coronary syndrome


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:4474

subject_name: Dezocine

object_name: adverse effect


subject: CHEBI:4474

object_name: Adverse effects


subject: CHEBI:4474

object_name: Adverse reactions


subject: CHEBI:9605

subject_name: Tirofiban


subject: UMLS:C4763658

subject_name: KRAS G12C inhibitor MRTX849

object_name: metastatic colorectal cancer


subject: CHEBI:233309

subject_name: Adagrasib


subject: UMLS:C3661302

subject_name: Infanrix hexa

object_name: diphtheria


subject: UMLS:C3661302

object_name: tetanus


subject: UMLS:C3661302

object_name: poliomyelitis


subject: UMLS:C3661302

object_name: hepatitis B


subject: CHEBI:3509

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: CHEBI:6770

subject_name: MEROPENEM


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:32816

subject_name: Pyruvic acid

object_name: plantar wart


subject: CHEBI:30762

subject_name: salicylate


subject: CHEBI:9008

subject_name: salicylurate


subject: CHEBI:16914

subject_name: Salicylic acid


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Presenile dementia


subject: CHEBI:6887

object_name: dementia


subject: CHEBI:6887

object_name: Gait Disorders, Neurologic


subject: CHEBI:32389

subject_name: MOROCTIC ACID

object_name: cardiovascular disorder


subject: CHEBI:32389

object_name: cardiac conduction defect


subject: CHEBI:32389

object_name: sudden cardiac arrest


subject: CHEBI:32389

object_name: Aborted sudden cardiac death


subject: CHEBI:9328

subject_name: Sulfadiazine


subject: CHEBI:9328


subject: CHEBI:9328


subject: CHEBI:9328


subject: PR:000014551

subject_name: protein SDA1


subject: PR:000014551


subject: PR:000014551


subject: PR:000014551


subject: CHEBI:63577

subject_name: Lamivudine

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:63577

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: PUBCHEM.COMPOUND:57414794


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate

object_name: adult glioblastoma


subject: CHEBI:50162

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:50162

object_name: Adult Gliosarcoma


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEBI:3638

subject_name: Chloroquine

object_name: Malaria, Vivax


subject: PUBCHEM.COMPOUND:12814875

subject_name: Artenimol


subject: PUBCHEM.COMPOUND:456410


subject: PUBCHEM.COMPOUND:540327

subject_name: Dihydroartemisinin


subject: CHEBI:91231

subject_name: Piperaquine


subject: UMLS:C2366367

subject_name: Cinryze

object_name: hereditary angioedema


subject: UMLS:C1699394

subject_name: Hylenex


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: metastatic colorectal cancer


subject: UNII:M316WT19D8

subject_name: Parnaparin

object_name: retinal vein occlusion


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:63005

subject_name: Sodium nitrate

object_name: acute kidney failure


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: B-cell neoplasm


subject: UNII:U59UGK3IPC

subject_name: Ublituximab


subject: UNII:U59UGK3IPC

object_name: mantle cell lymphoma


subject: UNII:U59UGK3IPC

object_name: non-Hodgkin lymphoma


subject: UNII:U59UGK3IPC

object_name: marginal zone lymphoma


subject: UNII:U59UGK3IPC

object_name: MALT lymphoma


subject: UNII:U59UGK3IPC

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: neuroendocrine neoplasm


subject: UMLS:C1676059

subject_name: TMC 278

object_name: HIV infection


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:135515

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: central retinal vein occlusion


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:8774

subject_name: Ramipril

object_name: glioblastoma


subject: CHEBI:8774

object_name: Childhood Glioblastoma


subject: CHEBI:8774

object_name: adult glioblastoma


subject: CHEBI:8774

object_name: Rash and Dermatitis Associated with Chemoradiation, CTCAE


subject: CHEBI:8774

object_name: Mental deterioration


subject: CHEBI:8774

object_name: Cognitive impairment


subject: CHEBI:8774

object_name: Disorder due to radiotherapy


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: primary central nervous system lymphoma


subject: CHEBI:165874

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:897NVD4A52

subject_name: p-Chloroamphetamine


subject: CHEBI:62248


subject: CHEBI:36751


subject: CHEBI:16010


subject: UMLS:C0034330

subject_name: Pidolic acid


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Finding of tear meniscus (eye)


subject: CHEBI:60802

object_name: Torn meniscus


subject: PUBCHEM.COMPOUND:152165

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:152165

object_name: Recurrent urinary tract infections


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: UNII:K3M925R42M

object_name: Childhood Solid Neoplasm


subject: UNII:K3M925R42M

object_name: Adult Solid Neoplasm


subject: UNII:K3M925R42M

object_name: Solid Neoplasm


subject: UMLS:C5555061

subject_name: SHP2 Inhibitor PF-07284892


subject: UMLS:C5555061


subject: UMLS:C5555061


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: CHEBI:74947

subject_name: Thalidomide

object_name: HIV infection


subject: CHEBI:74947

object_name: tuberculosis


subject: CHEBI:74947

object_name: Mycobacterium avium complex disease


subject: UMLS:C2742830

subject_name: Ismigen

object_name: Atopic rhinitis


subject: UMLS:C2742830

object_name: Allergic Rhinitis, CTCAE


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: breast cancer


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin

object_name: Intraoperative Hemorrhage


subject: UNII:8NZ41MIK1O

object_name: Venous thrombosis deep (limbs)


subject: CHEBI:231614

subject_name: Nivolumab

object_name: colorectal neoplasm


subject: UMLS:C2346820


subject: CHEBI:35045

subject_name: undecenoic acid


subject: CHEBI:35045

object_name: metastatic colorectal cancer


subject: CHEBI:35045

object_name: colorectal carcinoma


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C0665297

subject_name: natalizumab


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:18772499

object_name: obesity


subject: PUBCHEM.COMPOUND:18772499

object_name: Obesity, CTCAE


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: UNII:KV1M7Q3CBP

object_name: Ph-positive acute lymphoblastic leukemia


subject: UMLS:C2826372

subject_name: Mammaglobin-A DNA Vaccine


subject: UMLS:C2826372


subject: UMLS:C2826372


subject: UMLS:C2826372

object_name: Malignant melanoma of skin of breast


subject: UNII:30WLL6DR9O

subject_name: VONSETAMIG

object_name: chronic kidney disease


subject: UMLS:C5856926

subject_name: Vonsetamig


subject: UMLS:C4551608

subject_name: Sevorane

object_name: no feeling or sensation of skin


subject: UMLS:C4551608

object_name: Sensory Loss


subject: UMLS:C4551608

object_name: self-limited epilepsy with centrotemporal spikes


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:64816

object_name: non-Hodgkin lymphoma


subject: CHEBI:64816

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Burkitt lymphoma


subject: CHEBI:64816

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:64816

object_name: Adult Burkitt Lymphoma


subject: CHEBI:64816

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:64816


subject: CHEBI:64816

object_name: plasmablastic lymphoma


subject: CHEBI:64816

object_name: large-cell immunoblastic lymphoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690

object_name: B-cell neoplasm


subject: CHEBI:72690


subject: CHEBI:72690

object_name: diffuse large B-cell lymphoma


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: osteomyelitis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: end stage renal failure


subject: UNII:1C6V77QF41

object_name: Chronic uremia


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:10033

subject_name: Warfarin

object_name: coronary artery disorder


subject: CHEBI:10033

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: outcomes general quality of life


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Perceived quality of life


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Good quality of life


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: adverse effect


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Adverse effects


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Malignant cachexia


subject: UMLS:C3179325

subject_name: PRO 140

object_name: HIV infection


subject: PUBCHEM.COMPOUND:4622926

subject_name: Epothilone D

object_name: neoplasm


subject: UMLS:C1328652

subject_name: KOS 862


subject: UMLS:C0719605

subject_name: Cytogam

object_name: chronic kidney disease


subject: UMLS:C0719605


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab


subject: UNII:CUJ2MVI71Y


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C0281549


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: PUBCHEM.COMPOUND:50941212

subject_name: Avagacestat

object_name: Alzheimer disease


subject: UMLS:C3272706


subject: CHEBI:16796

subject_name: Melatonin

object_name: Malignant neoplasm of female breast


subject: CHEBI:16796

object_name: female breast carcinoma


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:87631


subject: CHEBI:9150

subject_name: Simvastatin


subject: UMLS:C4087048

subject_name: LentiGlobin BB305 Drug Product

object_name: sickle cell disease


subject: UMLS:C4087048

object_name: Cooley's anemia


subject: UNII:V16D2ZT7DT

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Wiskott-Aldrich syndrome


subject: CHEBI:91083

subject_name: Romiplostim


subject: UMLS:C1505595


subject: PUBCHEM.COMPOUND:3222

object_name: preeclampsia


subject: PUBCHEM.COMPOUND:3222

object_name: toxemia of pregnancy


subject: PUBCHEM.COMPOUND:3222

object_name: hypertension


subject: PUBCHEM.COMPOUND:3222

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:3222


subject: PUBCHEM.COMPOUND:3222

object_name: hypertension, pregnancy-induced


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Acute Stroke


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: UNII:WGD229O42W

subject_name: Tenecteplase


subject: UNII:WGD229O42W

object_name: cerebrovascular disorder


subject: CHEBI:59204

subject_name: Carbetocin

object_name: postpartum hemorrhage


subject: CHEBI:59204

object_name: Post-partum hemorrhage


subject: CHEBI:75431

subject_name: ghrelin

object_name: cystic fibrosis


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: UMLS:C0911014


subject: CHEBI:31401

subject_name: Cilostazol

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:31401

object_name: metabolic syndrome X


subject: CHEBI:139072

object_name: cocaine use disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:84883

subject_name: Icosapent ethyl

object_name: Inflammation


subject: CHEBI:84883

object_name: Community-Acquired Pneumonia


subject: UNII:7SE5582Q2P

subject_name: Vosoritide

object_name: Turner syndrome


subject: UNII:7SE5582Q2P

object_name: Noonan syndrome


subject: UNII:7SE5582Q2P

object_name: Noonan syndrome 1


subject: UMLS:C4085979

object_name: non-small cell lung carcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UMLS:C1328138

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C1328138

object_name: primary cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:11511576

subject_name: Tedizolid phosphate

object_name: skin disorder caused by infection


subject: PUBCHEM.COMPOUND:11511576

object_name: skin infection


subject: CHEBI:82717

subject_name: Tedizolid


subject: CHEBI:82717


subject: CHEBI:36791

subject_name: Escitalopram

object_name: anxiety


subject: CHEBI:36791

object_name: anxiety disorder


subject: CHEBI:36791

object_name: Anxiety symptoms


subject: CHEBI:36791

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:36791

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:36791

object_name: Encounter due to In vitro fertilization


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Decreased liver function


subject: CHEBI:4875

subject_name: Etanercept

object_name: Complication of transplanted lung


subject: UMLS:C1699394

subject_name: Hylenex

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:3249

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: glioblastoma


subject: UMLS:C0919144

object_name: Childhood Glioblastoma


subject: UMLS:C0919144

object_name: adult glioblastoma


subject: UMLS:C0919144

object_name: Adult Giant Cell Glioblastoma


subject: UMLS:C0919144

object_name: Childhood Giant Cell Glioblastoma


subject: UMLS:C0919144

object_name: giant cell glioblastoma


subject: UMLS:C0919144

object_name: Brain Stem Glioblastoma


subject: UMLS:C0919144

object_name: glioma susceptibility 1


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:74854

subject_name: Thr-Asp


subject: CHEBI:74854


subject: CHEBI:74854


subject: CHEBI:74854


subject: CHEBI:74854


subject: CHEBI:74854


subject: CHEBI:74854


subject: CHEBI:74854


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C0305060

subject_name: Tetanus and diphtheria toxoid adsorbed for adult use


subject: UMLS:C0305060


subject: UMLS:C0305060


subject: UMLS:C0305060


subject: UMLS:C0305060


subject: UMLS:C0305060


subject: UMLS:C0305060


subject: UMLS:C0305060


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:36219

subject_name: lactose

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:36219


subject: CHEBI:36218

subject_name: beta-lactose


subject: CHEBI:36218


subject: UMLS:C1260222

subject_name: Saccharum lactis, Homeopathic preparation


subject: UMLS:C1260222


subject: UMLS:C1696723

subject_name: lactose - non-drug agent


subject: UMLS:C1696723


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: complications of organ transplant stem cells


subject: CHEBI:66919

object_name: graft versus host disease


subject: CHEBI:66919

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:66919

object_name: acute myeloid leukemia


subject: CHEBI:66919

object_name: acute lymphoblastic leukemia


subject: CHEBI:64312

subject_name: Memantine

object_name: AOD effects and consequences


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Breast cancer stage III


subject: CHEBI:230905

object_name: Breast cancer stage II


subject: CHEBI:230905

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:233362

subject_name: Abemaciclib


subject: CHEBI:233362


subject: CHEBI:233362


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib


subject: UNII:5ZHA5P4PFX


subject: UNII:5ZHA5P4PFX


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Antisocial behavior


subject: CHEBI:25681

object_name: Encounter due to antisocial behavior


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Post-Operative Pain


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: type 2 diabetes mellitus


subject: UMLS:C1881373

object_name: Diabetes


subject: UMLS:C1881373

object_name: diabetes mellitus


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:207202

subject_name: SNAC


subject: CHEBI:207202


subject: CHEBI:207202


subject: UNII:1YTW0422YU

subject_name: Gum arabic


subject: UNII:1YTW0422YU


subject: UNII:1YTW0422YU


subject: CHEBI:9570

subject_name: Thiotepa

object_name: central nervous system cancer


subject: CHEBI:9570

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: female reproductive system disorder


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:63918

subject_name: Artesunate

object_name: intestinal cancer


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:38545

object_name: cardiovascular disorder


subject: CHEBI:38545

object_name: cerebrovascular disorder


subject: CHEBI:229225

subject_name: Bexagliflozin

object_name: essential hypertension


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: Ovarian germ cell cancer stage IV


subject: UNII:68AYS9A614

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: Recurrent Ovarian Germ Cell Tumor


subject: UNII:68AYS9A614

object_name: Adult Solid Neoplasm


subject: UNII:68AYS9A614

object_name: stage IIIA ovarian germ cell tumor


subject: UNII:68AYS9A614

object_name: Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: stage IIIB ovarian germ cell tumor


subject: UNII:68AYS9A614

object_name: Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: stage IIIC ovarian germ cell tumor


subject: UNII:68AYS9A614

object_name: Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: Adult Giant Cell Glioblastoma


subject: UNII:68AYS9A614

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:68AYS9A614

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:68AYS9A614

object_name: Metastatic non-small cell lung cancer


subject: UNII:68AYS9A614

object_name: Non-small cell lung cancer recurrent


subject: UNII:68AYS9A614

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage III renal cell cancer


subject: UNII:68AYS9A614

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IV Renal Cell Cancer


subject: UNII:68AYS9A614

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Pancreatic carcinoma stage III


subject: UNII:68AYS9A614

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: stage IV pancreatic cancer


subject: UNII:68AYS9A614

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Renal cell carcinoma recurrent


subject: UNII:68AYS9A614

object_name: Pancreatic carcinoma recurrent


subject: UNII:68AYS9A614

object_name: Adult Anaplastic Oligodendroglioma


subject: UNII:68AYS9A614

object_name: Adult Anaplastic Astrocytoma


subject: UNII:68AYS9A614

object_name: Recurrent Adult Brain Neoplasm


subject: UNII:68AYS9A614

object_name: adult anaplastic ependymoma


subject: UNII:68AYS9A614

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIC Ovarian Cancer


subject: UNII:68AYS9A614

object_name: Stage IIIB Breast Carcinoma


subject: UNII:68AYS9A614

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:68AYS9A614

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: stage IIIC melanoma


subject: UNII:68AYS9A614

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: stage IIIA rectal cancer


subject: UNII:68AYS9A614

object_name: Recurrent Rectal Cancer


subject: UNII:68AYS9A614

object_name: Breast cancer recurrent


subject: UNII:68AYS9A614

object_name: stage IVA rectal cancer


subject: UNII:68AYS9A614

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: malignant large intestine neoplasm stage IIIb


subject: UNII:68AYS9A614

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: stage IVB rectal cancer


subject: UNII:68AYS9A614

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Ovarian cancer stage IV


subject: UNII:68AYS9A614

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Colon cancer recurrent


subject: UNII:68AYS9A614

object_name: stage IVB colon cancer


subject: UNII:68AYS9A614

object_name: Stage IVB Colon Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IVB Colon Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: Carcinoma breast stage IV


subject: UNII:68AYS9A614

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: stage IVA colon cancer


subject: UNII:68AYS9A614

object_name: Stage IVA Colon Cancer AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IVA Colon Cancer AJCC v8


subject: UNII:68AYS9A614

object_name: stage IIIB melanoma


subject: UNII:68AYS9A614

object_name: stage IIIA melanoma


subject: UNII:68AYS9A614

object_name: male breast carcinoma


subject: UNII:68AYS9A614

object_name: adult brainstem glioma


subject: UNII:68AYS9A614

object_name: Adult Mixed Glioma


subject: UNII:68AYS9A614

object_name: Melanoma recurrent


subject: UNII:68AYS9A614

object_name: adult glioblastoma


subject: UNII:68AYS9A614

object_name: Adult Gliosarcoma


subject: UMLS:C2711999

subject_name: cediranib maleate

object_name: Ovarian germ cell cancer stage IV


subject: UMLS:C2711999

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2711999

object_name: Recurrent Ovarian Germ Cell Tumor


subject: UMLS:C2711999

object_name: Adult Solid Neoplasm


subject: UMLS:C2711999

object_name: stage IIIA ovarian germ cell tumor


subject: UMLS:C2711999

object_name: Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2711999

object_name: stage IIIB ovarian germ cell tumor


subject: UMLS:C2711999

object_name: Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2711999

object_name: stage IIIC ovarian germ cell tumor


subject: UMLS:C2711999

object_name: Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2711999

object_name: Adult Giant Cell Glioblastoma


subject: UMLS:C2711999

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C2711999

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C2711999

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C2711999

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C2711999

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage III renal cell cancer


subject: UMLS:C2711999

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C2711999

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C2711999

object_name: Pancreatic carcinoma stage III


subject: UMLS:C2711999

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C2711999

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C2711999

object_name: stage IV pancreatic cancer


subject: UMLS:C2711999

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C2711999

object_name: Renal cell carcinoma recurrent


subject: UMLS:C2711999

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C2711999

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C2711999

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C2711999

object_name: Recurrent Adult Brain Neoplasm


subject: UMLS:C2711999

object_name: adult anaplastic ependymoma


subject: UMLS:C2711999

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2711999

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2711999

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2711999

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C2711999

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2711999

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C2711999

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2711999

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2711999

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UMLS:C2711999

object_name: stage IIIC melanoma


subject: UMLS:C2711999

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UMLS:C2711999

object_name: stage IIIA rectal cancer


subject: UMLS:C2711999

object_name: Recurrent Rectal Cancer


subject: UMLS:C2711999

object_name: Breast cancer recurrent


subject: UMLS:C2711999

object_name: stage IVA rectal cancer


subject: UMLS:C2711999

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UMLS:C2711999

object_name: malignant large intestine neoplasm stage IIIb


subject: UMLS:C2711999

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UMLS:C2711999

object_name: stage IVB rectal cancer


subject: UMLS:C2711999

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2711999

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C2711999

object_name: Ovarian cancer stage IV


subject: UMLS:C2711999

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UMLS:C2711999

object_name: Colon cancer recurrent


subject: UMLS:C2711999

object_name: stage IVB colon cancer


subject: UMLS:C2711999

object_name: Stage IVB Colon Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IVB Colon Cancer AJCC v8


subject: UMLS:C2711999

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C2711999

object_name: Carcinoma breast stage IV


subject: UMLS:C2711999

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2711999

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2711999

object_name: stage IVA colon cancer


subject: UMLS:C2711999

object_name: Stage IVA Colon Cancer AJCC v7


subject: UMLS:C2711999

object_name: Stage IVA Colon Cancer AJCC v8


subject: UMLS:C2711999

object_name: stage IIIB melanoma


subject: UMLS:C2711999

object_name: stage IIIA melanoma


subject: UMLS:C2711999

object_name: male breast carcinoma


subject: UMLS:C2711999

object_name: adult brainstem glioma


subject: UMLS:C2711999

object_name: Adult Mixed Glioma


subject: UMLS:C2711999

object_name: Melanoma recurrent


subject: UMLS:C2711999

object_name: adult glioblastoma


subject: UMLS:C2711999

object_name: Adult Gliosarcoma


subject: UMLS:C2742210

object_name: Ovarian germ cell cancer stage IV


subject: UMLS:C2742210

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2742210

object_name: Recurrent Ovarian Germ Cell Tumor


subject: UMLS:C2742210

object_name: Adult Solid Neoplasm


subject: UMLS:C2742210

object_name: stage IIIA ovarian germ cell tumor


subject: UMLS:C2742210

object_name: Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2742210

object_name: stage IIIB ovarian germ cell tumor


subject: UMLS:C2742210

object_name: Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2742210

object_name: stage IIIC ovarian germ cell tumor


subject: UMLS:C2742210

object_name: Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2742210

object_name: Adult Giant Cell Glioblastoma


subject: UMLS:C2742210

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C2742210

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C2742210

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C2742210

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C2742210

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage III renal cell cancer


subject: UMLS:C2742210

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C2742210

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C2742210

object_name: Pancreatic carcinoma stage III


subject: UMLS:C2742210

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C2742210

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C2742210

object_name: stage IV pancreatic cancer


subject: UMLS:C2742210

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C2742210

object_name: Renal cell carcinoma recurrent


subject: UMLS:C2742210

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C2742210

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C2742210

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C2742210

object_name: Recurrent Adult Brain Neoplasm


subject: UMLS:C2742210

object_name: adult anaplastic ependymoma


subject: UMLS:C2742210

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2742210

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2742210

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2742210

object_name: Recurrent ovarian cancer


subject: UMLS:C2742210

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C2742210

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C2742210

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2742210

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UMLS:C2742210

object_name: stage IIIC melanoma


subject: UMLS:C2742210

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UMLS:C2742210

object_name: stage IIIA rectal cancer


subject: UMLS:C2742210

object_name: Recurrent Rectal Cancer


subject: UMLS:C2742210

object_name: Breast cancer recurrent


subject: UMLS:C2742210

object_name: stage IVA rectal cancer


subject: UMLS:C2742210

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UMLS:C2742210

object_name: malignant large intestine neoplasm stage IIIb


subject: UMLS:C2742210

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UMLS:C2742210

object_name: stage IVB rectal cancer


subject: UMLS:C2742210

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2742210

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C2742210

object_name: Ovarian cancer stage IV


subject: UMLS:C2742210

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UMLS:C2742210

object_name: Colon cancer recurrent


subject: UMLS:C2742210

object_name: stage IVB colon cancer


subject: UMLS:C2742210

object_name: Stage IVB Colon Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IVB Colon Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C2742210

object_name: Carcinoma breast stage IV


subject: UMLS:C2742210

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: stage IVA colon cancer


subject: UMLS:C2742210

object_name: Stage IVA Colon Cancer AJCC v7


subject: UMLS:C2742210

object_name: Stage IVA Colon Cancer AJCC v8


subject: UMLS:C2742210

object_name: stage IIIB melanoma


subject: UMLS:C2742210

object_name: stage IIIA melanoma


subject: UMLS:C2742210

object_name: male breast carcinoma


subject: UMLS:C2742210

object_name: adult brainstem glioma


subject: UMLS:C2742210

object_name: Adult Mixed Glioma


subject: UMLS:C2742210

object_name: Melanoma recurrent


subject: UMLS:C2742210

object_name: adult glioblastoma


subject: UMLS:C2742210

object_name: Adult Gliosarcoma


subject: CHEBI:6078

subject_name: Ivermectin

object_name: Pediculus humanus capitis infestation


subject: CHEBI:9139

subject_name: Sildenafil

object_name: habitual spontaneous abortion


subject: CHEBI:49603

subject_name: Lapatinib

object_name: HER2 positive


subject: CHEBI:31348

subject_name: Capecitabine


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:681569

subject_name: Clofarabine

object_name: osteopetrosis


subject: UMLS:C2003521

subject_name: insulin aspart, insulin aspart protamine drug combination 30:70

object_name: type 1 diabetes mellitus 1


subject: UMLS:C2003521

object_name: type 1 diabetes mellitus


subject: UMLS:C3886322

object_name: Lumbosacral radiculopathy


subject: CHEBI:67271

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:67271

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:67271

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:67271

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:67271

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:67271

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:67271

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:67271

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:67271

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:67271

object_name: stage IA breast cancer


subject: CHEBI:67271

object_name: triple-negative breast carcinoma


subject: CHEBI:67271

object_name: Progesterone Receptor Positive


subject: CHEBI:67271

object_name: Progesterone Receptor Negative


subject: CHEBI:67271

object_name: Estrogen Receptor Negative


subject: CHEBI:67271

object_name: Estrogen Receptor Positive


subject: CHEBI:67271

object_name: HER2 positive


subject: CHEBI:67271

object_name: HER2/Neu Negative


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: Left Ventricular Systolic Dysfunction, CTCAE 3.0


subject: PUBCHEM.COMPOUND:24993045

object_name: Left Ventricular Systolic Dysfunction, CTCAE 5.0


subject: PUBCHEM.COMPOUND:24993045

object_name: Left ventricular systolic dysfunction


subject: UMLS:C3529192


subject: UMLS:C3529192


subject: UMLS:C3529192


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Brain Stem Glioblastoma


subject: UNII:2S9ZZM9Q9V

object_name: glioma susceptibility 1


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Depressed mood


subject: CHEBI:7465

object_name: Cancer patients and suicide and depression


subject: CHEBI:7465

object_name: Depressed - symptom


subject: CHEBI:7465

object_name: Depression, CTCAE


subject: CHEBI:9123

subject_name: Sertraline

object_name: alcohol abuse


subject: CHEBI:9123

object_name: alcohol dependence


subject: UNII:PSQ4R5K1QI

object_name: hepatitis C


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Skin Wrinkling


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: PUBCHEM.COMPOUND:46874763

object_name: Soft Tissue Injuries


subject: UMLS:C0003232

subject_name: Antibiotics


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Childhood Rectal Carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:95073

subject_name: Ricolinostat

object_name: peripheral nervous system disorder


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: chronic hepatitis B virus infection


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:71940

subject_name: Tadalafil

object_name: vascular dementia


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C4329335

subject_name: IBI 308

object_name: esophageal squamous cell carcinoma


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: coronary artery disorder


subject: UNII:2XLN4Y044H

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: PUBCHEM.COMPOUND:22451303


subject: CHEBI:143658

object_name: leukemia


subject: CHEBI:143658

object_name: childhood leukemia


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Seroma, CTCAE


subject: CHEBI:60648

object_name: Seroma


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C5446895

subject_name: Anti-CTLA-4 Monoclonal Antibody IBI310

object_name: non-small cell lung carcinoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335


subject: UMLS:C5706549

subject_name: Anti-PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363


subject: UMLS:C5667057

subject_name: Cafelkibart


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: liver failure


subject: PUBCHEM.COMPOUND:70789204

object_name: liver disorder


subject: PUBCHEM.COMPOUND:70789204

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:70789204

object_name: liver neoplasm


subject: UMLS:C4330704

object_name: indolent systemic mastocytosis


subject: UMLS:C4287781

object_name: neoplasm


subject: UNII:5V1UI86573

subject_name: EZABENLIMAB


subject: UMLS:C4329334

subject_name: Ezabenlimab


subject: MESH:C116580

subject_name: fructooligosaccharide

object_name: irritable bowel syndrome


subject: UMLS:C4727634

subject_name: CT-053 Tosylate

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C4727634

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:30021

subject_name: Selenomethionine

object_name: Hashimoto thyroiditis


subject: CHEBI:30021

object_name: autoimmune thyroid disease


subject: UMLS:C1517683

subject_name: L-Selenomethionine


subject: UMLS:C1517683


subject: UNII:4I67US2V8Q

object_name: Depressed mood


subject: UNII:4I67US2V8Q

object_name: Cancer patients and suicide and depression


subject: UNII:4I67US2V8Q

object_name: Depressed - symptom


subject: UNII:4I67US2V8Q

object_name: Depression, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3545406


subject: CHEMBL.COMPOUND:CHEMBL3545406


subject: CHEMBL.COMPOUND:CHEMBL3545406


subject: CHEMBL.COMPOUND:CHEMBL3545406


subject: UNII:TUK9QB44B0

object_name: cancer


subject: UNII:TUK9QB44B0


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Pregnancy in Diabetics


subject: CHEBI:17925

object_name: gestational diabetes


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:32599

object_name: Threatened premature labor


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Malignant melanoma stage III


subject: UMLS:C2346820